[Continuous subcutaneous insulin infusion].
Ito
H
H
Second Department of Internal Medicine, Chiba University School of Medicine.
Kanatsuka
A
A
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D007332:Insulin Infusion Systems / Q000009:adverse effects; D010349:Patient Compliance
D007004:Hypoglycemic Agents; D007328:Insulin